Harold C. Simmons Comprehensive Cancer Center - Director, Precision Oncology
The Simmons Comprehensive Cancer Center (SCCC) at UT Southwestern Medical Center seeks a dynamic, accomplished physician scientist and leader to serve as the inaugural Director of Precision Oncology. This is an exceptional opportunity at a rapidly growing, NCI designated comprehensive cancer center. Located in Dallas, Texas, one of the fastest growing and most diverse parts of the country, the SCCC is positioned for exponential growth over the course of the next several years. The inaugural Director will have the opportunity to leverage this growth and advancement as he/she builds out Precision Oncology within a prominent cancer center and top-tier academic institution.
Nationally recognized for the quality of clinical care and world renowned for its basic and translational research, UT Southwestern is an academic medical center regarded among the best in the country. Its mission, “promoting health and a healthy society that enables achievement of full human potential,” integrates daily in how UT Southwestern educates, discovers, and heals to ensure quality outcomes for its students, faculty, and patients.
Embedded within UT Southwestern is the Simmons Comprehensive Cancer Center, one of 51 Comprehensive Cancer Centers in the country designated by the National Cancer Institute (NCI) and home to many of the nation’s top cancer specialists. Treating over 24,000 patients per year, across four sites, the SCCC has 243 members from 34 departments in UT Southwestern. Each year UT Southwestern receives more than $100 million in cancer research funding with at least 30% coming from the NCI. In March 2020, the National Comprehensive Cancer Network (NCCN) announced the Simmons Cancer Center would join its alliance of 30 distinguished cancer centers throughout the country. In June 2019, the Simmons Cancer Center broke ground on a nine-story tower that will add 300,000 square feet for outpatient cancer care and clinical trials. Construction of a second three-story radiation oncology building was completed in early 2021. The strategic planning of the SCCC prioritizes translational cancer research, cancer discovery, cancer focused funding, multidisciplinary cancer care and a regional expansion, cancer clinical trials, community outreach & engagement, cancer education and training, and addressing cancer health disparities.
Reporting to the Director of the SCCC, Dr. Carlos Arteaga, the Director of Precision Oncology will lead a multidisciplinary program focused on cancer genomics, biomarker discovery, and genotype driven clinical trials. The successful candidate will be a clinically active physician scientist, have experience in an academic medical center or similarly complex environment and a track record of peer-reviewed funding and translational research in precision oncology. The Director will have a collaborative style and be able to effectively manage in a highly matrixed system and inspire a team.
To find out more, contact Kimberly Smith, Morten Nielsen, and Walter Ettinger, M.D., through the office of Ashley Rittgers, preferably via email to email@example.com or by phone at (740) 412-7940.
UT Southwestern Medical Center values diversity and is committed to equal opportunity for all persons regardless of age, color, disability, ethnicity, marital status, national origin, race, religion, sex, sexual orientation, veteran status, or any other status protected by law.